Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2017 Nov;96(45):e8613.
doi: 10.1097/MD.0000000000008613.

Circulating 25-hydroxyvitamin D and lung cancer risk and survival: A dose-response meta-analysis of prospective cohort studies

Qianqian Feng  1 , Han Zhang, Zhengqin Dong, Yang Zhou, Jingping Ma
Affiliations
Meta-Analysis

Circulating 25-hydroxyvitamin D and lung cancer risk and survival: A dose-response meta-analysis of prospective cohort studies

Qianqian Feng et al. Medicine (Baltimore). 2017 Nov.

Abstract

Lower serum level of 25-hydroxyvitamin D is associated with several negative outcomes. However, previous studies have indicated that 25-hydroxyvitamin D is associated with lung cancer risk and survival, but presented controversial results.PubMed and Embase databases were searched update to August 2017 to identify and quantify the potential association between 25-hydroxyvitamin D and lung cancer risk and survival.Seventeen eligible studies involving a total of 138,858 participants with 4368 incident cases were included in this meta-analysis. Our results showed statistically significant association between 25-hydroxyvitamin D and lung cancer risk and mortality. However, circulating 25-hydroxyvitamin D was not associated with overall lung cancer survival. Furthermore, compared with the lowest circulating 25-hydroxyvitamin D, the highest circulating 25-hydroxyvitamin D is significantly decreased risk of lung cancer risk in male and female. In addition, the highest circulating 25-hydroxyvitamin D was significantly associated with a lower risk in Caucasian and Asian. We also obtained the best fit at an inflection point of 10 nmol/L in piecewise regression analysis, increasing 10 nmol/L dose of circulating 25-hydroxyvitamin D was associated with an 8% reduction in the risk of lung cancer risk and an 7% reduction in the risk of lung cancer mortality. Subgroup meta-analyses in study quality, number of participants, and number of cases showed consistent with the primary findings.The highest circulating 25-hydroxyvitamin D was associated with decreased lung cancer risk and mortality but not overall survival.

PubMed Disclaimer

Conflict of interest statement

The authors have no funding and conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Flow diagram of the study selection process.
Figure 2
Figure 2
Circulating 25-hydroxyvitamin D is associated with lung cancer risk.
Figure 3
Figure 3
Circulating 25-hydroxyvitamin D is associated with lung cancer mortality.
Figure 4
Figure 4
Circulating 25-hydroxyvitamin D is associated with lung cancer survival.
See this image and copyright information in PMC

References

    1. Jemal A, Bray F, Center M, et al. Global cancer statistics. CA Cancer J Clin 2011;61:69–90. - PubMed
    1. Zeng H, Zheng R, Guo Y, et al. Cancer survival in China, 2003–2005: a population-based study. Int J Cancer 2015;136:1921–30. - PubMed
    1. Miller K, Siegel R, Lin C, et al. Cancer treatment and survivorship statistics. CA Cancer J Clin 2016;66:271–89. - PubMed
    1. Ezzati M, Lopez A. Estimates of global mortality attributable to smoking in 2000. Lancet 2003;362:847–52. - PubMed
    1. Kushi L, Doyle C, McCullough M, et al. American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 2012;62:30–67. - PubMed

Publication types